We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 30

Researchers identify antibiotic-resistant bacteria in pig manure
  • Shook Hardy & Bacon LLP
  • China, USA
  • February 15 2013

A new study has reportedly confirmed the presence of antibiotic-resistant genes (ARGs) in manure samples harvested from swine farms in China, raising


CFDA seeks comments on revisions to cosmetics regulations
  • Shook Hardy & Bacon LLP
  • China
  • September 26 2013

The China Food and Drug Administration (CFDA) has issued a notice inviting comments on its "Regulations concerning the Hygiene Supervision over


WHO reports first documented human case of avian influenza A
  • Shook Hardy & Bacon LLP
  • China, USA
  • December 20 2013

The World Health Organization (WHO) has reported the first documented case of avian influenza A (H10N8) in a human patient from Jiangxi Province


Engineered avian and swine flu hybrids raise concerns about mammal-to-mammal transmission
  • Shook Hardy & Bacon LLP
  • China
  • May 10 2013

Chinese scientists investigating the spread of airborne influenzas have reportedly combined genetic material from avian (H5N1) and swine (H1N1) flu


China’s medical device regulations take effect June 1
  • Shook Hardy & Bacon LLP
  • China
  • May 1 2014

According to news sources, China's amended medical device rules, which increase fines for illegal manufacturing and strengthen government oversight


China to establish food and safety ‘blacklist’
  • Shook Hardy & Bacon LLP
  • China, USA
  • December 20 2013

The Chinese Food and Drug Administration (CFDA) has announced a public consultation on a draft regulation, "Provisions on the Administration of the


Chinese billionaire backs U.S.China biopharma venture
  • Shook Hardy & Bacon LLP
  • USA, China
  • April 21 2011

Chinese real-estate billionaire Qi Jinzing has reportedly begun investing in the biotech sector despite its potential financial risks


Premature development causes unease in China
  • Shook Hardy & Bacon LLP
  • China, USA
  • August 20 2010

Chinese health experts have reportedly estimated that "at least 30,000 children developed early maturity" in Shanghai alone, raising concerns about food additives and pesticides allegedly laden with sex hormones


Chinese health officials investigate infant formula linked to early onset puberty
  • Shook Hardy & Bacon LLP
  • China
  • August 13 2010

The Chinese Ministry of Health has apparently announced an investigation into claims linking infant formula manufactured by Synutra International, Inc., to early onset puberty


Large-scale joint drug venture and MOUs bind North Carolina and China’s Zhejian
  • Shook Hardy & Bacon LLP
  • China, USA
  • August 4 2011

North Carolina’s Hamner Institutes for Health Sciences and Ascletis Inc., a U.S.-China pharmaceutical company, have signed a memorandum of understanding (MOU) to support the first large-scale joint venture in biotechnology between North Carolina and China’s Zhejian Province